Adage Capital Partners’s Janux Therapeutics JANX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $58.3M | Sell |
2,525,000
-1,129,574
| -31% | -$26.1M | 0.1% | 198 |
|
|
2025
Q1 | $98.7M | Buy |
3,654,574
+592,824
| +19% | +$16M | 0.18% | 114 |
|
|
2024
Q4 | $164M | Buy |
3,061,750
+986,750
| +48% | +$52.8M | 0.29% | 56 |
|
|
2024
Q3 | $94.3M | Sell |
2,075,000
-252,896
| -11% | -$11.5M | 0.17% | 114 |
|
|
2024
Q2 | $97.5M | Sell |
2,327,896
-447,776
| -16% | -$18.8M | 0.18% | 112 |
|
|
2024
Q1 | $105M | Buy |
2,775,672
+1,420,197
| +105% | +$53.5M | 0.2% | 107 |
|
|
2023
Q4 | $14.5M | Buy |
1,355,475
+205,475
| +18% | +$2.2M | 0.03% | 515 |
|
|
2023
Q3 | $11.6M | Buy |
1,150,000
+250,000
| +28% | +$2.52M | 0.03% | 533 |
|
|
2023
Q2 | $10.7M | Hold |
900,000
| – | – | 0.02% | 563 |
|
|
2023
Q1 | $10.9M | Buy |
900,000
+198,934
| +28% | +$2.41M | 0.02% | 599 |
|
|
2022
Q4 | $9.23M | Buy |
701,066
+301,066
| +75% | +$3.97M | 0.02% | 655 |
|
|
2022
Q3 | $5.42M | Hold |
400,000
| – | – | 0.01% | 770 |
|
|
2022
Q2 | $4.88M | Hold |
400,000
| – | – | 0.01% | 801 |
|
|
2022
Q1 | $5.74M | Hold |
400,000
| – | – | 0.01% | 811 |
|
|
2021
Q4 | $7.89M | Hold |
400,000
| – | – | 0.01% | 764 |
|
|
2021
Q3 | $8.65M | Sell |
400,000
-50,000
| -11% | -$1.08M | 0.02% | 735 |
|
|
2021
Q2 | $11.2M | Buy |
+450,000
| New | +$11.2M | 0.02% | 657 |
|